Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring Outcomes and Risk in Patients With Rare Central Nervous System Tumors

NCT03251989 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03251989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03251989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring Outcomes and Risk in Patients With Rare Central Nervous System Tumors
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
August 21, 2017
Completion date
May 6, 2025
Enrollment
326 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ependymoma, high grade meningioma, medulloblastoma, pnet, primary cns sarcoma